• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蜂毒素-dKLA 靶向肿瘤相关巨噬细胞在黑色素瘤中的治疗作用。

Therapeutic Effect of Melittin-dKLA Targeting Tumor-Associated Macrophages in Melanoma.

机构信息

Department of Physiology, College of Korean Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemoon-gu, Seoul 02447, Korea.

Department of Science in Korean Medicine, College of Korean Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemoon-gu, Seoul 02447, Korea.

出版信息

Int J Mol Sci. 2022 Mar 13;23(6):3094. doi: 10.3390/ijms23063094.

DOI:10.3390/ijms23063094
PMID:35328518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8954064/
Abstract

Melanoma is an immunogenic tumor and a serious type of skin cancer. Tumor-associated macrophages (TAMs) express an M2-like phenotype and are involved in all stages of melanomagenesis; it is hence a promising target for cancer immunotherapy. We herein investigated whether melittin-dKLA inhibits the growth of melanoma by inducing apoptosis of M2-like macrophages. For the in vitro study, a conditioned medium of macrophages was prepared from M0, M1, or M2-differentiated THP-1 cells with and without melittin-dKLA. The affinity of melittin for M2 macrophages was studied with FITC (fluorescein isothiocyanate)-conjugated melittin. For the in vivo study, murine melanoma cells were inoculated subcutaneously in the right flank of mice, melittin-dKLA was intraperitoneally injected at 200 nmol/kg every three days, and flow cytometry analysis of TAMs was performed. Since melittin binds preferentially to M2-like macrophages, melittin-dKLA induced more caspase 3 expression and cell death in M2 macrophages compared with M0 and M1 macrophages and melanoma cells. Melittin-dKLA significantly inhibited the proliferation and migration of M2 macrophages, resulting in a decrease in melanoma tumor growth in vivo. The CD206 M2-like TAMs were reduced, while the CD86 M1-like TAMs were not affected. Melittin-dKLA is therapeutically effective against melanoma by inducing the apoptosis of M2-like TAMs.

摘要

黑色素瘤是一种免疫原性肿瘤,也是一种严重的皮肤癌。肿瘤相关巨噬细胞(TAMs)表达 M2 样表型,并参与黑色素瘤发生的所有阶段;因此,它是癌症免疫治疗的一个有前途的靶点。我们在此研究了蜂毒素-dKLA 是否通过诱导 M2 样巨噬细胞凋亡来抑制黑色素瘤的生长。在体外研究中,用和不用蜂毒素-dKLA 从 M0、M1 或 M2 分化的 THP-1 细胞制备巨噬细胞条件培养基。用 FITC(异硫氰酸荧光素)缀合的蜂毒素研究蜂毒素与 M2 巨噬细胞的亲和力。在体内研究中,将鼠黑色素瘤细胞皮下接种于小鼠右侧肋部,每三天腹腔内注射 200nmol/kg 的蜂毒素-dKLA,并进行 TAMs 的流式细胞术分析。由于蜂毒素优先与 M2 样巨噬细胞结合,与 M0 和 M1 巨噬细胞和黑色素瘤细胞相比,蜂毒素-dKLA 诱导 M2 巨噬细胞中更多的 caspase 3 表达和细胞死亡。蜂毒素-dKLA 显著抑制 M2 巨噬细胞的增殖和迁移,导致体内黑色素瘤肿瘤生长减少。CD206 M2 样 TAMs 减少,而 CD86 M1 样 TAMs 不受影响。蜂毒素-dKLA 通过诱导 M2 样 TAMs 凋亡对黑色素瘤具有治疗效果。

相似文献

1
Therapeutic Effect of Melittin-dKLA Targeting Tumor-Associated Macrophages in Melanoma.蜂毒素-dKLA 靶向肿瘤相关巨噬细胞在黑色素瘤中的治疗作用。
Int J Mol Sci. 2022 Mar 13;23(6):3094. doi: 10.3390/ijms23063094.
2
Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide.基于蜂毒素的促凋亡肽靶向 M2 样肿瘤相关巨噬细胞。
J Immunother Cancer. 2019 Jun 7;7(1):147. doi: 10.1186/s40425-019-0610-4.
3
Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer.优化蜂毒素-dKLA 对三阴性乳腺癌中 M2 样肿瘤相关巨噬细胞的靶向治疗作用。
Int J Mol Sci. 2022 Dec 12;23(24):15751. doi: 10.3390/ijms232415751.
4
Melittin derived peptide-drug conjugate, M-DM1, inhibits tumor progression and induces effector cell infiltration in melanoma by targeting M2 tumor-associated macrophages.蜂毒素衍生肽-药物偶联物 M-DM1 通过靶向 M2 肿瘤相关巨噬细胞抑制黑色素瘤的肿瘤进展并诱导效应细胞浸润。
Front Immunol. 2023 Apr 14;14:1178776. doi: 10.3389/fimmu.2023.1178776. eCollection 2023.
5
TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer.TAMpepK 通过消除三阴性乳腺癌中的 M2 样肿瘤相关巨噬细胞来抑制转移。
Int J Mol Sci. 2022 Feb 15;23(4):2157. doi: 10.3390/ijms23042157.
6
Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.基于 M2 样肿瘤相关巨噬细胞靶向纳米复合物的肿瘤微环境重塑与肿瘤治疗。
Theranostics. 2021 Jan 1;11(6):2892-2916. doi: 10.7150/thno.50928. eCollection 2021.
7
Melittin suppresses tumor progression by regulating tumor-associated macrophages in a Lewis lung carcinoma mouse model.在Lewis肺癌小鼠模型中,蜂毒肽通过调节肿瘤相关巨噬细胞来抑制肿瘤进展。
Oncotarget. 2017 Jun 27;8(33):54951-54965. doi: 10.18632/oncotarget.18627. eCollection 2017 Aug 15.
8
Melittin Induced G1 Cell Cycle Arrest and Apoptosis in Chago-K1 Human Bronchogenic Carcinoma Cells and Inhibited the Differentiation of THP-1 Cells into Tumour- Associated Macrophages.蜂毒肽诱导人支气管癌细胞Chago-K1的G1期细胞周期阻滞和凋亡,并抑制THP-1细胞分化为肿瘤相关巨噬细胞。
Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3427-3434. doi: 10.31557/APJCP.2018.19.12.3427.
9
Bee Venom Melittin Protects against Cisplatin-Induced Acute Kidney Injury in Mice via the Regulation of M2 Macrophage Activation.蜂毒肽通过调节 M2 巨噬细胞活化来保护小鼠顺铂诱导的急性肾损伤。
Toxins (Basel). 2020 Sep 6;12(9):574. doi: 10.3390/toxins12090574.
10
Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.靶向 CAMKII 重塑肿瘤相关巨噬细胞并抑制肿瘤细胞的可注射杂合肽水凝胶用于癌症免疫治疗。
Theranostics. 2020 Feb 10;10(7):3049-3063. doi: 10.7150/thno.42385. eCollection 2020.

引用本文的文献

1
Myristoyl-CM4 Exhibits Direct Anticancer Activity and Immune Modulation in Hepatocellular Carcinoma: Evidence from In Vitro and Mouse Model Studies.肉豆蔻酰化CM4在肝细胞癌中表现出直接抗癌活性和免疫调节作用:来自体外和小鼠模型研究的证据。
Int J Mol Sci. 2025 Apr 18;26(8):3829. doi: 10.3390/ijms26083829.
2
Melittin promotes the proliferation of Schwann cells in hyperglycemic environment by up‑regulating the Crabp2/Wnt/β‑catenin signaling pathway.蜂毒素通过上调 Crabp2/Wnt/β-连环蛋白信号通路促进高糖环境中施万细胞的增殖。
Mol Med Rep. 2025 Jan;31(1). doi: 10.3892/mmr.2024.13371. Epub 2024 Oct 25.
3
Targeting tumor-associated macrophages: Novel insights into immunotherapy of skin cancer.

本文引用的文献

1
Immune checkpoint inhibitors in melanoma.黑色素瘤的免疫检查点抑制剂。
Lancet. 2021 Sep 11;398(10304):1002-1014. doi: 10.1016/S0140-6736(21)01206-X.
2
Targeting Tumor-Associated Macrophages to Increase the Efficacy of Immune Checkpoint Inhibitors: A Glimpse into Novel Therapeutic Approaches for Metastatic Melanoma.靶向肿瘤相关巨噬细胞以提高免疫检查点抑制剂的疗效:转移性黑色素瘤新型治疗方法一瞥
Cancers (Basel). 2020 Nov 17;12(11):3401. doi: 10.3390/cancers12113401.
3
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1.
靶向肿瘤相关巨噬细胞:皮肤癌免疫治疗的新见解
J Adv Res. 2025 Jan;67:231-252. doi: 10.1016/j.jare.2024.01.013. Epub 2024 Jan 17.
4
Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies.基于蜂毒素的纳米粒在抗肿瘤治疗中的最新进展:从作用机制到靶向递药策略。
J Nanobiotechnology. 2023 Nov 28;21(1):454. doi: 10.1186/s12951-023-02223-4.
5
Melittin: a possible regulator of cancer proliferation in preclinical cell culture and animal models.蜂毒素:一种可能在临床前细胞培养和动物模型中调节癌症增殖的物质。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17709-17726. doi: 10.1007/s00432-023-05458-8. Epub 2023 Nov 3.
6
An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers.一篇综述更新总结了蜂毒中的蜂肽在几种人类癌症模型中的抗癌功效。
Nutrients. 2023 Jul 12;15(14):3111. doi: 10.3390/nu15143111.
7
Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting.肿瘤相关巨噬细胞亚群:塑造极化和靶向。
Int J Mol Sci. 2023 Apr 19;24(8):7493. doi: 10.3390/ijms24087493.
8
Machine learning-based construction of immunogenic cell death-related score for improving prognosis and response to immunotherapy in melanoma.基于机器学习构建免疫原性细胞死亡相关评分,以改善黑色素瘤的预后和免疫治疗反应。
Aging (Albany NY). 2023 Apr 6;15(7):2667-2688. doi: 10.18632/aging.204636.
9
Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer.优化蜂毒素-dKLA 对三阴性乳腺癌中 M2 样肿瘤相关巨噬细胞的靶向治疗作用。
Int J Mol Sci. 2022 Dec 12;23(24):15751. doi: 10.3390/ijms232415751.
通过靶向鞘氨醇激酶-1 克服黑色素瘤对免疫检查点抑制剂的耐药性。
Nat Commun. 2020 Jan 23;11(1):437. doi: 10.1038/s41467-019-14218-7.
4
M2 tumor-associated macrophages promote tumor progression in non-small-cell lung cancer.M2型肿瘤相关巨噬细胞促进非小细胞肺癌的肿瘤进展。
Exp Ther Med. 2019 Dec;18(6):4490-4498. doi: 10.3892/etm.2019.8068. Epub 2019 Sep 30.
5
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells.免疫系统逃逸作为黑色素瘤进展的标志:树突状细胞的作用。
Front Oncol. 2019 Nov 5;9:1148. doi: 10.3389/fonc.2019.01148. eCollection 2019.
6
Age-Specific Incidence of Melanoma in the United States.美国特定年龄段的黑色素瘤发病率。
JAMA Dermatol. 2020 Jan 1;156(1):57-64. doi: 10.1001/jamadermatol.2019.3353.
7
Tumor-associated macrophages induce invasion and poor prognosis in human gastric cancer in a cyclooxygenase-2/MMP9-dependent manner.肿瘤相关巨噬细胞以环氧化酶-2/基质金属蛋白酶-9依赖的方式诱导人类胃癌的侵袭和不良预后。
Am J Transl Res. 2019 Sep 15;11(9):6040-6054. eCollection 2019.
8
TRIM59 loss in M2 macrophages promotes melanoma migration and invasion by upregulating MMP-9 and Madcam1.M2巨噬细胞中TRIM59缺失通过上调MMP-9和Madcam1促进黑色素瘤的迁移和侵袭。
Aging (Albany NY). 2019 Oct 10;11(19):8623-8641. doi: 10.18632/aging.102351.
9
The Role of Tumor-Associated Macrophages in Leukemia.肿瘤相关巨噬细胞在白血病中的作用。
Acta Haematol. 2020;143(2):112-117. doi: 10.1159/000500315. Epub 2019 Jul 9.
10
Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide.基于蜂毒素的促凋亡肽靶向 M2 样肿瘤相关巨噬细胞。
J Immunother Cancer. 2019 Jun 7;7(1):147. doi: 10.1186/s40425-019-0610-4.